✦ LIBER ✦

Secukinumab improves hand, foot and nail lesions in moderate-to-severe plaque psoriasis: subanalysis of a randomized, double-blind, placebo-controlled, regimen-finding phase 2 trial

✍ Scribed by Paul, C.; Reich, K.; Gottlieb, A.B.; Mrowietz, U.; Philipp, S.; Nakayama, J.; Harfst, E.; Guettner, A.; Papavassilis, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Secukinumab induction and maintenance th

✍ Rich, P.; Sigurgeirsson, B.; Thaci, D.; Ortonne, J.-P.; Paul, C.; Schopf, R.E.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

Efficacy and safety of secukinumab in th

✍ Papp, K.A.; Langley, R.G.; Sigurgeirsson, B.; Abe, M.; Baker, D.R.; Konno, P.; H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Impact of ustekinumab on health-related

✍ Hidemi NAKAGAWA; Brad SCHENKEL; Mai KATO; Takeshi KATO; Atsuyuki IGARASHI; The J 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 317 KB

A phase IV randomized, double-blind, pla

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Ustekinumab significantly improves sympt

✍ Richard G. Langley; Steven R. Feldman; Chenglong Han; Brad Schenkel; Philippe Sz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Efficacy and safety of itolizumab, a nov

✍ Krupashankar, D.S.; Dogra, Sunil; Kura, Mahendra; Saraswat, Abir; Budamakuntla, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 694 KB